CALGB90202_2B: CALGB90202, figure 2B

CALGB90202_2BR Documentation

CALGB90202, figure 2B

Description

Kaplan-Meier digitized data from CALGB90202, figure 2B (PMID 24590644). A reported sample size of 645 for a primary endpoint of time_SRE in prostate cancer.

Usage

CALGB90202_2B

Format

A data frame of 645 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (placebo, za)

Source

Smith MR, Halabi S, Ryan CJ, et al. Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance). J Clin Oncol 2014; 32: 1143–50.

Examples

summary(CALGB90202_2B)

kmplot(CALGB90202_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.